- Histopathology
- Cytopathology
- Molecular Pathology
Pathological Examination Market size was valued at approximately USD 263.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. Pathological examination refers to the study of tissues and cells to diagnose diseases and determine their causes and effects. This market encompasses various techniques, equipment, and services used in histopathology, cytopathology, and molecular pathology.
The growth of the pathological examination market is driven by factors such as the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, rising demand for personalized medicine, and growing investments in healthcare infrastructure. For instance, the integration of artificial intelligence and digital pathology solutions has significantly improved the efficiency and accuracy of pathological examinations. However, challenges such as the high cost of advanced pathology equipment, the shortage of skilled pathologists in some regions, and concerns about the standardisation of pathology practices may hinder market growth to some extent.
Pathological Examination Market Key Developments:
- On May 1, 2024, Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
Pathological Examination Market Summary
Study Period
2024-2030Base Year
2023CAGR
3.1%Largest Market
North-AmericaFastest Growing Market
North-AmericaPathological Examination Market Dynamics
The pathological examination market is primarily driven by the rising incidence of chronic diseases and disorders, including chronic lung diseases, cardiac diseases, cancer, type 2 diabetes, and stroke, as well as the increasing global mortality rates associated with these conditions. The emergence of infectious diseases such as COVID-19 has heightened the need for accurate diagnosis and treatment, further propelling market growth. Pathological examinations are extensively utilized in healthcare for disease diagnosis, treatment determination, and aiding medical professionals in providing optimal treatment options. The market is also influenced by the increasing research and development activities and higher investment in these areas. Additionally, factors such as the growing geriatric population, rising public awareness about examinations, improved healthcare infrastructure, and increased healthcare spending positively impact the pathological examination market. Moreover, the advent of digital pathology, technological advancements, and innovations offer lucrative opportunities for market players from 2024 to 2030.
North-America Got Significant Share of
Pathological Examination Market Regional Analysis
North America accounted for the largest revenue share in the pathological examination market in 2023. The region's dominance is attributed to well-established healthcare infrastructure, high healthcare expenditure, and the presence of leading market players. The United States, in particular, has seen significant adoption of digital pathology solutions and molecular diagnostic techniques. The Asia-Pacific region is projected to experience the fastest growth in the pathological examination market. This expansion is driven by improving healthcare infrastructure, increasing healthcare spending, and growing awareness about early disease detection. Countries such as China, Japan, and India are expected to be key contributors to this growth, with rising investments in healthcare technology and an increasing burden of chronic diseases.
Latin America
Europe
Asia Pacific
Middle East
North America
Pathological Examination Market Segmentation
By Type
By Application
- Cancer
- Infectious Diseases
- Genetic Disorders
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Research Institutes
Frequently Asked Questions
The global pathological examination market size was valued at approximately USD 263.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030.
Key drivers include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, rising demand for personalized medicine, and growing investments in healthcare infrastructure.
The main challenges include the high cost of advanced pathology equipment, the shortage of skilled pathologists in some regions, and concerns about the standardisation of pathology practices.
The key players in the pathological examination market include Roche Diagnostics, Danaher Corporation, Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, Hologic, Inc., Agilent Technologies, Becton, Dickinson and Company, Sakura Finetek Japan Co., Ltd., and Leica Biosystems (Danaher).
Key Features of the Report
- The pathological examination market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Pathological Examination Market Introduction |
| 2.1.Global Pathological Examination Market - Taxonomy |
| 2.2.Global Pathological Examination Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Pathological Examination Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Pathological Examination Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Pathological Examination Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Histopathology |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Cytopathology |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Molecular Pathology |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Pathological Examination Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Cancer |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Infectious Diseases |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Genetic Disorders |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Pathological Examination Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Laboratories |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Institutes |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Pathological Examination Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Histopathology |
| 9.1.2.Cytopathology |
| 9.1.3.Molecular Pathology |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cancer |
| 9.2.2.Infectious Diseases |
| 9.2.3.Genetic Disorders |
| 9.2.4.Others |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Diagnostic Laboratories |
| 9.3.3.Research Institutes |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Histopathology |
| 10.1.2.Cytopathology |
| 10.1.3.Molecular Pathology |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cancer |
| 10.2.2.Infectious Diseases |
| 10.2.3.Genetic Disorders |
| 10.2.4.Others |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Diagnostic Laboratories |
| 10.3.3.Research Institutes |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Histopathology |
| 11.1.2.Cytopathology |
| 11.1.3.Molecular Pathology |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cancer |
| 11.2.2.Infectious Diseases |
| 11.2.3.Genetic Disorders |
| 11.2.4.Others |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Diagnostic Laboratories |
| 11.3.3.Research Institutes |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Histopathology |
| 12.1.2.Cytopathology |
| 12.1.3.Molecular Pathology |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cancer |
| 12.2.2.Infectious Diseases |
| 12.2.3.Genetic Disorders |
| 12.2.4.Others |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Diagnostic Laboratories |
| 12.3.3.Research Institutes |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Histopathology |
| 13.1.2.Cytopathology |
| 13.1.3.Molecular Pathology |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cancer |
| 13.2.2.Infectious Diseases |
| 13.2.3.Genetic Disorders |
| 13.2.4.Others |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Diagnostic Laboratories |
| 13.3.3.Research Institutes |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Agilent Technologies |
| 14.2.2.Abbott Laboratories |
| 14.2.3.Becton, Dickinson and Company |
| 14.2.4.Roche Diagnostics |
| 14.2.5.Danaher Corporation |
| 14.2.6.Thermo Fisher Scientific |
| 14.2.7.Siemens Healthineers |
| 14.2.8.Hologic, Inc. |
| 14.2.9.Sakura Finetek Japan Co., Ltd. |
| 14.2.10.Leica Biosystems (Danaher) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Agilent Technologies
- Abbott Laboratories
- Becton, Dickinson and Company
- Roche Diagnostics
- Danaher Corporation
- Thermo Fisher Scientific
- Siemens Healthineers
- Hologic, Inc.
- Sakura Finetek Japan Co., Ltd.
- Leica Biosystems (Danaher)